Therapeutic Advances in Hematology

Papers
(The H4-Index of Therapeutic Advances in Hematology is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Brain iron content and cognitive function in patients with β-thalassemia27
Monocyte or white blood cell counts and β2 microglobulin predict the durable efficacy of daratumumab with lenalidomide27
Prognostic impact of IL7R mutations on acute myeloid leukemia26
Effective engraftment via granulocyte transfusion in pre-engraftment febrile neutropenia following allogeneic hematopoietic stem cell transplantation: granulocyte transfusion as bridge therapy26
Integrated genetic, epigenetic, and immune landscape of TP53 mutant AML and higher risk MDS treated with azacitidine24
BEST study: one-year descriptive follow-up of bevacizumab treatment in hereditary haemorrhagic telangiectasia post-BABH interventional study23
The importance of terminal complement inhibition in paroxysmal nocturnal hemoglobinuria21
Outcomes of patients with diffuse large B-cell and high-grade B-cell lymphomas with synchronous CNS and systemic involvement at diagnosis treated with high-dose methotrexate and R-CHOP: a single-cente19
Successful maintenance of a sustained molecular response in CML patients receiving low-dose tyrosine kinase inhibitors19
Role of abatacept in the prevention of graft-versus-host disease: current perspectives18
A comparison of the effect of three different comorbidity indices on overall survival in patients with chronic myeloid leukemia18
Treatment of multiple myeloma: What is the impact on T-cell function?18
Macrofocal multiple myeloma in the era of novel agents in China15
Pomalidomide- and dexamethasone-based regimens in the treatment of refractory/relapsed multiple myeloma15
0.050058841705322